LabRoots and the Cell Biology Planning Committee are pleased to announce the 4th Annual Cell Biology Virtual Event, providing an opportunity to discuss recent discoveries in biological research, advancements in techniques, and tool developments in cell research.
Cell Biology 2020 Virtual Event will continue to create a valuable platform for inspiring global and interdisciplinary collaboration in a virtual environment, to study cells – their physiological properties, structure, the organelles they contain, environmental interactions, life cycle, division and death, on a microscopic and molecular level.
This years event will include the following tracks and topics:
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event. The webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.
Like the 2019 conference, this event will be produced on our robust platform, allowing you to watch, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system, you can now move around the entire event, earning points for a chance to win one of LabRoots' most popular T-shirts.
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Cell Biology Virtual Event. Submission is free. Submit your abstract here.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Use #LRcellbio to follow the conversation!
POSTER SUBMISSION GUIDELINES
Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.
SUBMIT YOUR ABSTRACT
Enter the following information to this Submission Form:
All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.
If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.
Questions? Email Posters@LabRoots.com
Prof. Benedetta Bussolati obtained her medical degree at the University of Torino (Italy) and her PhD on Physiopathology of the Renal Insufficiency at the University of Parma (Italy). She currently holds the position of Associate Professor of Nephrology at the University of Torino and director of a Research group at the Molecular Biotechnology Centre. Dr. Bussolati has extensive experience in studies of stem cell biology and regenerative medicine that include characterization of various stem cell types and their potential use for tissue regeneration. She is actually focusing on the role extracellular vesicles as therapeutic tools for modulating tissue regeneration, angiogenesis and tumor vasculogenesis. She is founder and president of the Italian Society of Extracellular Vesicles (EVIta).
John J.S. Cadwell received his degree in pharmacology from the University of Miami in 1981 studying excitation/contraction coupling mechanisms in skeletal muscle. He spent additional time at the University of Nottingham and the National Institute of Medical Research at Mill Hill, U.K.. In 2000 he founded FiberCell Systems Inc., a company specializing in the develop and supply of laboratory scale 3-D capillary hollow fiber bioreactors. He is also founder of FiberCell Laboratories, the research and development arm for FiberCell Systems. He has over 10 publications in the field and three patents relating to hollow fiber systems and has presented talks on various related topics at meetings around the world.
Steve Caplan received his PhD from the Lautenberg Center for Tumor and General Immunology at the Hebrew University Hadassah Medical Center, Jerusalem, Israel, in 1998. He trained as a postdoctoral fellow between 1998 and 2003 at the National Institutes of Health, before accepting a faculty position in the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center (UNMC) in Omaha, Nebraska in 2003. Dr. Caplan is currently a Professor and Vice Chair for Administration, and serves as the Director of the UNMC Advanced Microscopy Core Facility, as well as the Research Institute-Program Coordinator for the Nebraska INBRE Program, an NIH-funded program designed to improve the research infrastructure for the state of Nebraska and to encourage and promote undergraduate science research. Dr. Caplan has received multiple awards, including Outstanding Faculty Mentor of Graduate Students, UNMC Distinguished Scientist and the Thomas Maciag award for mentorship and research. Dr. Caplan is the author of about 100 published manuscripts, as well as 4 novels of fiction that deal with the lives of scientists, and has written a series of articles for newspapers such as The Guardian in the UK.
Paolo Cravedi, MD, PhD, is an Associate Professor in the Division of Nephrology in the Department of Medicine. Dr. Paolo Cravedi is a scientist physician with a strong interest in kidney transplantation and autoimmune glomerular diseases. During his clinical training as nephrologist in Italy, he designed clinical research studies in kidney transplant recipients and in individuals with renal diseases aimed at prolonging survival of the graft or the native kidneys, respectively. His studies have contributed to defining the organ allocation system currently used in many countries around the world. He subsequently completed his postdoctoral training at the Icahn School of Medicine at Mount Sinai, where he identified unanticipated immune effects of erythropoietin. While Dr. Cravedi’s lab is still interested in understanding the mechanisms of alloreactive immune responses, it has more recently expanded its focus to study the pathogenesis of autoimmune glomerular disease.
Dr Hakim Djaballah holds a BSc degree from the University of Birmingham (England) and a doctorate degree from the University of Leicester (England). He is the co-founder, president & CEO of Keren Therapeutics, a startup company dedicated to the science of aging. Formerly, he was the CEO of the Pasteur Institute in South Korea, a translational research institute with a focus on infectious diseases and oncology. Dr Djaballah was affiliated with the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, USA. He has over 25 year’s industrial and academic experience in drug discovery and development. Dr Djaballah is a molecular pharmacologist and technologist with expertise in infectious diseases & oncology, & a thought leader on drug discovery and development and sits on several national & international advisory boards. To date, he has published more than 96 articles, book chapters, and reviews. He is an inventor on a number of patents, a founder of two biotechnology companies, and the recipient of the 2007 Robots and Vision User Recognition Award.
Dr. Muller Fabbri is Associate Professor and co-Leader of the Cancer Biology Program at the University of Hawai’i Cancer Center (UHCC) in Honolulu, HI, USA. He also is the Scientific Lead of the Micro- and Nano-Scale Cancer Therapeutics Initiative at UHCC. Dr. Fabbri has provided the first evidence that microRNAs delivered to surrounding cells of the Tumor Microenvironment through extracellular vesicles can bind to Toll-like receptors and trigger downstream signaling pathways highly impactful on cancer biology. Dr. Fabbri is author of more than 90 peer reviewed publications, he has authored several book chapters, serves in the Editorial Board of many international scientific Journals. Dr. Fabbri’s lab is focused on studying how microRNAs (and other non-coding RNAs) are communicating between cancer cells and surrounding cells of the tumor microenvironment and how this affects cancer biology and the development of resistance to chemo and radiotherapy.
As the Product Manager for GeoMx RNA portfolio, Kit Fuhrman develops cutting edge assays for the Digital Spatial Profiling platform for morphology driven expression profiling. He is proud to have release the Cancer Transcriptome Atlas, the first high-plex NGS enabled product on GeoMx, and is hard at work developing Whole Transcriptome Assays for GeoMx. Prior to his six years at NanoString, Kit received his doctorate from University of Florida in immunology studying the role of regulatory T cells in type-1 diabetes pathogenesis and his master’s from the University of Central Florida directed design of HIV entry inhibitors.
Katherine Mechling, B.Sci., is a scientist with MilliporeSigma, the life science business of Merck KGaA, Darmstadt, Germany, where she has led development efforts for GenElute™-E nucleic acid sample preparation products and assisted with the development of mPAGE™ SDS-PAGE precast gels and accessories. Currently, she is optimizing workflows for specific applications (isolation, quantitation, electrophoresis, and blotting) for both nucleic acids and proteins and is also leading efforts for sustainable product development. Ms. Mechling has over 10 years of experience in molecular biology including development and validation of assays for clinical diagnostic applications (such as cancer and pathogen detection), as well as pharmacokinetic ligand binding assay development.
I received my BS in Biology from the University of California Riverside and my Doctor of Philosophy (Ph.D.) in Development, Stem Cells, and Regenerative Medicine (DSR) from the USC Keck School of Medicine. My dissertation focused on "Renal extracellular matrix bioactivity in a range of physiological states: novel insights for kidney regeneration." As a Senior Postdoctoral Research Fellow for the past four years, I have worked on multiple topics, including the ECM characterization in the developing kidney and Wilms' Tumor, and how the ECM influences self-renewal of nephron progenitors in kidney development and cancer. I am a member of the American Society of Transplantation TRM-COP, and I am on the editorial board of the International Journal of Clinical and Experimental Medical Sciences.
Sargis Sedrakyan, Ph.D. is a Children’s Hospital Los Angeles and Saban Research Institute Investigator and Assistant Professor of Urology at the University of Southern California. Dr. Sedrakyan received his undergraduate degree in Biology at Brooklyn College, the City University of New York, his Ph.D. in Stem Cells and Regenerative Medicine from University of Padua, Italy and completed a postdoctoral research training in Developmental Biology and Regenerative Medicine at The Saban Research Institute, Children’s Hospital Los Angeles and the University of Southern California. His research focuses on understanding the etiology and development of chronic kidney diseases, with an emphasis on the functional role of glomerular endothelial cells, and the development of stem cell-derived extracellular vesicle based applications to treat kidney disease.
Kevin Su received a Bachelor of Science degree from the University of California, Irvine in 2000. During his time there, he worked as a research associate in the departments of Pathology, Medicine/Immunology, and Pharmacology where he conducted research for cell signaling projects, prostate cancer, Ataxia-telangiectasia (AT), and G-protein coupled receptors (GPCRs). Since joining MilliporeSigma in 2006, he has developed multiple GPCR stable cell lines for drug screening services and many of the FlowCellect™ Kits for the Guava® easyCyte flow cytometry platform. Kevin also developed the first industry autophagy stable cell lines including green fluorescent protein (GFP) and red fluorescent protein (RFP) versions in CHO and U2OS cells. Kevin also evaluated dyes for MilliporeSigma’s live-cell dyes portfolio. He is currently focused on research and development of MilliporeSigma’s three-dimensional (3D) organoid systems, specifically the 3dGROTM Human iPSC Derived Colon Organoids.
Dr. Daniel Suter studied Biology at the ETH Zurich in Switzerland, receiving a BS degree in Biological Sciences in 1988. He conducted graduate research on neuronal cell adhesion molecules with Prof. Peter Sonderegger in the Department of Biochemistry at the University of Zurich. After receiving a PhD in Biochemistry in 1995, he joined the laboratory of Prof. Paul Forscher at Yale University as a Postdoctoral fellow with support from the Swiss National Science Foundation and the Roche Research Foundation. During his time at Yale University, Dr. Suter made significant contributions to the understanding of the underlying mechanisms of neuronal growth cone motility and guidance, using quantitative high-resolution live cell imaging techniques. For example, he provided the first direct experimental evidence that support the model of substrate-cytoskeletal coupling during growth cone migration. In 2003, he started his own lab at Purdue University as an Assistant Professor of Biological Sciences, continuing to unravel the basic cellular and molecular mechanisms that control the directional movements of neuronal growth cones. His independent research program has focused on the dynamics and mechanics of axonal growth during development and regeneration following injury using both Aplysia and zebrafish as model systems. Since 2017, Dr. Suter is a Professor of Biological Sciences in the Department of Biological Sciences and member of the Purdue Institute for Integrative Neuroscience at Purdue University.
Mr. West, has been actively working in the field of medical device product development since earning his MS in biomedical product development from the University of Kansas (2011); a masters certificate in entrepreneurship from Nanyang Technological University in Singapore (2009) thanks to a scholarship from the Kauffman Foundation; and BS in mechanical engineering from the University of Kansas (2008). In addition to founding two companies he has worked in all aspects of medical product development from prototyping and proof of concept, through CAD, design and manufacturability. He has worked in production, served as head of regulatory, and developed quality management systems that comply with the requirements of ISO-13485:2016 and cGMP. He's a natural problem solver and works at the intersection of business and engineering.
Marina received her BSc at Tartu University in Estonia at the Department of Cell and Molecular Biology. In 2001 she moved to Sweden and started her MSc in Molecular Genetics at Department of Plant Biology in Swedish University of Agricultural Sciences. Marina completed her PhD at Department of Genetics and Pathology in Rudbeck Laboratory at Uppsala University. Her thesis was dealing with epigenetic changes of transcription factor genes in haematopoietic tumours. From 2009 employed as an application specialist in the technical and application support team, providing customers with: assay designs and evaluations, seminars and workshops. For the last 5 years working as Field Marketing Specialist for Cell Culture portfolio.
Kenneth Witwer is an associate professor of molecular and comparative pathobiology at the Johns Hopkins University School of Medicine and is affiliated with the Richman Family Precision Medicine Center of Excellence in Alzheimer's Disease. The Witwer laboratory studies the roles of extracellular vesicles and extracellular RNA in health and disease, especially in neurodegenerative disease and enveloped virus infection. Dr. Witwer has served as secretary general and executive chair of science and meetings with the International Society for Extracellular Vesicles and is an associate editor at the Journal of Extracellular Vesicles.
James Zou is an assistant professor of biomedical data science and, by courtesy, of CS and EE at Stanford University. James develops novel machine learning algorithms that have strong statistical guarantees and that are motivated by biomedical and human health challenges. Several of his methods are widely used by tech, biotech and pharma companies. He also works on questions important for the broader impacts of AI—e.g. interpretations, robustness, fairness, and data governance. He has received the NSF CAREER Award, a Google Faculty Award, a Tencent AI award and is a Chan-Zuckerberg Investigator.
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling. Its product range includes pipettes and automated pipetting systems, centrifuges, mixers, spectrometers, and DNA amplification ...See more See less
Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results. By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to ...See more See less
LI-COR first introduced scientific instruments for plant science research and quickly grew to provide scientists tools for such diverse disciplines as atmospheric research and the study of how proteins interact at the cellular level. LI-COR Biosciences is a global leader in the ...See more See less
Manuscriptedit specializes in providing services in Scientific & English editing, proofreading, medical writing, academic writing, formatting and publication support. Within a short span of time, the company has grown rapidly to be counted among the world's leading service ...See more See less
With a portfolio of more than 4,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in ...See more See less
Our purpose is to solve the toughest problems in life science by collaborating with the global scientific community - and through that, we aim to accelerate access to better health for people everywhere.
OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. The availability of the complete human genome sequence and the subsequent development of genome-based ...See more See less
For more than 30 years, GoldBio has been committed to researchers around the world. We know providing quality reagents to scientists leads to discoveries that benefit all. That is why we provide our customers with only the best chemicals, tested in GoldBio labs to ensure the ...See more See less
Andor are global leaders in the development and manufacture of high performance scientific digital cameras, microscopy systems and spectrographs for academic, industrial and government applications. Through continuous dialogue with our customers and strong teamwork, we continue ...See more See less
For more than 35 years, TRC has provided innovative and highly specialised complex organics to the worldwide research community. Our expansive range of products are used in a wide array of application areas, including pharmaceutical and medicinal R&D, forensic science, and ...See more See less
The speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Dr. Aguilar obtained his PhD degree in Immunochemistry from the School of Pharmacy and Biochemistry, University of Buenos Aires, Argentina. Dr. Aguilar pursued his post-doctoral training at the National institutes of Health in Bethesda, MD in the lab of the well-known cell ...See more See less
Matt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...See more See less
Dr. Laura Perin is an Assistant Professor at the Keck School of Medicine, University of Southern California. Dr Perin obtained a master's degree in Biological Sciences at the University of Padova, Italy in 2000 and a Ph.D. in Stem cells and Tissue Engineering at the Harvard ...See more See less
Leading Novabiosis' primary cell business, Matthew brings to the Company a skill for implementing sales-driven business strategies, an extensive track record of meeting and surpassing targeted sales objectives, and a passion for translating customer needs into solutions that ...See more See less
|Operating System||Internet Explorer||Firefox||Chrome||Safari|
|Windows 7||IE8+||FF10+||Chrome15+||Windows 8||IE10||FF10+||Chrome15+|
|Mac OS X||FF10+||Chrome15+||Safari5.1+|
- For viewing Webinars:
- For viewing Virtual Events